Neurology billing sits at the intersection of high-complexity clinical care and intricate procedure coding. This combination generates significant revenue when you bill correctly, yet it triggers substantial write-offs when your team misses the mark. EEG interpretation, electromyography (EMG), nerve conduction studies (NCS), infusion therapy, and neuropsychological testing each feature distinct coding structures, rigid documentation requirements, and payer-specific coverage criteria. Furthermore, because practices face an expanding prior authorization burden and payers increasingly use AI-assisted claim reviews, neurology billing precision matters more than ever in 2026.
This comprehensive guide covers the vital CPT codes your neurology billing team must master. In addition, it outlines the exact documentation standards that protect each service line and highlights the denial patterns that most frequently impact neurology practices.
Neurology E/M: Documenting Complexity in a High-Complexity Specialty
Neurological patients frequently present with conditions that easily support high-complexity medical decision making (MDM). These cases often involve multiple chronic neurological diagnoses, medication management with significant drug-interaction risks, and extensive data reviews covering imaging, prior neuropsychological testing, and outside medical records. Despite this reality, many neurology practices consistently undercode their Evaluation and Management (E/M) visits because their documentation does not explicitly articulate the clinical complexity that actually exists.
Key 2026 Documentation Principle: For a level 5 established patient visit (99215), your medical decision making must clearly reflect high complexity. This means you must document “a condition that poses a threat to life or bodily function” or management decisions involving “drug therapy requiring intensive monitoring for toxicity.”
Clinical scenarios such as epilepsy with breakthrough seizures, ALS progression assessments, or acute MS relapse management frequently meet this high threshold. Therefore, your providers must document these factors explicitly to defend the code.
EEG Billing: Routine, Extended, and Ambulatory Procedures
Neurology practices bill electroencephalography (EEG) based on the specific format of the test (routine, extended, ambulatory, or video-EEG), the setup duration, and who handles the components. Your team must differentiate between the technical component (the actual recording) and the professional component (the physician’s interpretation).
Routine EEG (95816–95819)
95816: Electroencephalogram (EEG); awake and drowsy
95819: Electroencephalogram (EEG); awake and asleep
95822: Electroencephalogram (EEG); sleep only
95824: Electroencephalogram (EEG); cerebral death evaluation only
Routine EEGs include a global code that combines both the technical and professional services. However, payers also split them into separate professional (modifier -26) and technical (modifier -TC) components. If your practice performs the EEG in-office and your neurologist interprets the data, you should bill the global code. Conversely, if a local hospital performs the technical recording and your neurologist only interprets the results, you must append modifier -26 to protect the claim from an automatic rejection.
Long-Term EEG Monitoring (95700–95726)
Long-term monitoring codes are strictly time-based. Because of this requirement, your documentation must detail the exact recording duration, the monitoring setting, and the specific clinical indication. Ambulatory EEG setups that patients wear at home carry highly specific coverage criteria under most insurance plans and almost universally require prior authorization. Additionally, the final interpretation report must explicitly address each recorded clinical event and the overall impression; a generic or brief summary will not survive a payer audit.
Video EEG
Video-EEG for seizure characterization stands out as one of the highest-value neurology procedures, but it also remains one of the most heavily audited lines. Practices report the technical setup and the professional interpretation separately. To establish clear medical necessity, your clinical documentation must outline the prevailing uncertainty regarding seizure type or semiology, proving that only video correlation can resolve the clinical question.
EMG and Nerve Conduction Study Billing
Electromyography and nerve conduction studies represent the most frequently billed neurology procedures after standard E/M visits. Unfortunately, they also face the highest rate of medical necessity denials.
Nerve Conduction Studies (95907–95913)
Billing teams report NCS codes using a tiered system based on the total number of individual studies performed. In this context, a “study” refers to an individual motor, sensory, or mixed nerve tested:
95907: 1–2 nerve conduction studies
95908: 3–4 nerve conduction studies
95909: 5–6 nerve conduction studies
95910: 7–8 nerve conduction studies
95911: 9–10 nerve conduction studies
95912: 11–12 nerve conduction studies
95913: 13 or more nerve conduction studies
The Most Common Billing Error: Selecting an NCS tier based on the total number of recorded waveforms rather than the number of individual nerves tested. Your billers must count the nerves, not the waveforms. Additionally, your electrodiagnostic (EDX) report must document each specific nerve alongside its measured conduction velocities, amplitudes, and latencies.
Needle EMG (95860–95872)
Coders select needle EMG codes based on the exact number of extremities studied and whether the physician included the paraspinal muscles. When a provider performs an EMG and an NCS on the same day for the same patient, you should report them as separate line items because payers do not bundle them automatically. However, your clinical documentation must independently establish the medical necessity for both procedures.
Prior Authorization Note: Most commercial payers and Medicare Advantage plans require prior authorization for EMG/NCS testing. Your authorization requests must explicitly document the patient’s clinical symptoms, the duration of those symptoms, and the objective reasons why electrodiagnostic testing is necessary. For example, writing “rule out carpal tunnel syndrome” is insufficient. Instead, use specific language such as: “Bilateral hand numbness and weakness for 6 months with positive Tinel’s sign and failed conservative therapy.”
Infusion Therapy Billing in Neurology
Intravenous infusions for neurological conditions—such as IVIG for myasthenia gravis, natalizumab for MS, or rituximab for neuromyelitis optica—provide an excellent revenue stream for practices with in-office infusion suites. Infusion billing is strictly time-based. Consequently, your clinical team must document the specific drug infused, the route of administration, the rate of flow, exact start and stop times, and continuous nursing observations.
96365: Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour
96366: Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour (add-on code)
96367: Additional sequential infusion of a new drug; up to 1 hour (add-on code)
96368: Concurrent infusion (add-on code)
96372: Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular
Your team must bill the therapeutic drug itself separately using the correct HCPCS J-code (such as J1561 for IVIG or J2323 for natalizumab). Because Medicare reimburses drug costs for in-office infusions at the Average Sales Price (ASP) plus 6%, you should always verify that your drug acquisition cost sits safely below the active reimbursement rate before treating patients.
Botulinum Toxin Injections for Neurological Conditions
Medicare and most commercial insurance plans offer solid coverage for botulinum toxin injections (such as Botox/onabotulinumtoxinA) to treat chronic migraine, cervical dystonia, and upper limb spasticity. Billers must report the procedure code separately from the drug supply code (J0585 for onabotulinumtoxinA, billed strictly per unit).
64615: Chemodenervation of muscle(s); muscle(s) innervated by facial, trigeminal, cervical spinal and accessory nerves, bilateral (chronic migraine)
64616: Chemodenervation of muscle(s); neck muscle(s), severe (cervical dystonia)
64642–64647: Chemodenervation of muscle(s); extremities (spasticity codes)
Documentation Requirement: To secure coverage for chronic migraine injections (defined as 15 or more headache days per month), the medical record must document the precise number of headache days, the failure of past preventive therapies, the exact injection sites, and the total units administered. Including a clear anatomical diagram or photo of the injection sites within the patient chart is standard practice and greatly simplifies audit defense.
Common Neurology Billing Denials in 2026
Medical Necessity Denials for EMG/NCS
Payers are applying highly restrictive clinical criteria for electrodiagnostic studies. As a result, the statement “clinical documentation does not support medical necessity” has become the most common denial reason. To prevent this issue, ensure your ordering notes explicitly detail the patient’s duration of symptoms, physical examination findings, and why the clinical question requires electrodiagnostic testing.
Unbundling of EDX Components
Certain payers mistakenly attempt to bundle EMG and NCS codes into a single payment during processing. When this occurs, your billing team should immediately submit the remittance advice along with the supporting medical documentation to prove both procedures were distinct and necessary. File a formal appeal citing national coding guidelines to recover your revenue.
Long-Term EEG Prior Authorization Failures
Ambulatory and video EEG setups frequently trigger denials because the billing team failed to secure prior authorization before the study. For elective long-term monitoring, you should embed authorization checks directly into your scheduling workflow. For urgent inpatient video EEG, most payers allow retrospective authorizations within 24 to 48 hours, so your team must pursue this variance immediately.
Infusion Drug Coverage Mismatches
Practices sometimes experience automatic denials because they administer an in-office drug covered under Medicare Part D (pharmacy benefit) instead of Medicare Part B (medical benefit). If you bill a Part D drug on a medical claim, the system will reject it instantly. Always verify the designated coverage pathway for every infusion drug before the patient sits in the chair.
Building a High-Performance Neurology Billing Operation
Ultimately, neurology billing rewards coding teams who understand fine clinical distinctions. Your staff must know the real differences between routine and extended EEG setups, between a 9-nerve and a 13-nerve NCS study, and between chemodenervation for dystonia versus spasticity. These are not arbitrary clerical choices; they represent fundamental differences in the clinical services provided and the reimbursement your practice deserves.
The neurology team at Right On Time Medical Billing includes certified coders who possess specialized electrodiagnostic and infusion experience. We manage prior authorizations, precise code selection, proactive documentation reviews, and aggressive denial management for neurology practices across all 50 states. Contact us today to schedule your free neurology coding accuracy review and protect your practice’s bottom line.
Free Neurology Coding Accuracy Review
Verify your EEG, EMG, and infusion billing is capturing every dollar you've earned.